The results of clinical research suggested that in severe COVID-19 patients, intercellular adhesion molecule 1 (ICAM-1), also known as cluster of differentiation 54 (CD54), was significantly elevated, but it was reduced during the recovery period. The gene discussed is ICAM1; the disease is COVID-19.